GeneTex
  • Country / Location Selection

United States (US)

SLC39A13 blocking peptide

Cat. No. GTX31995-PEP

Application

Neutralizing/Inhibition
Package
50 μg ($139)
PRODUCT

Summary

SLC39A13 peptide is used for blocking the activity of SLC39A13 antibody (catalog number GTX31995).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Solute Carrier Family 39 Member 13 , Edsspd3 , Lzt-Hs9 , Scdeds , Zip13 , Slc39A13

Background

This gene encodes a member of the LIV-1 subfamily of the ZIP transporter family. The encoded transmembrane protein functions as a zinc transporter. Mutations in this gene have been associated with the spondylocheiro dysplastic form of Ehlers-Danlos syndrome.[provided by RefSeq, Mar 2010]

Research Area

REFERENCE

There are currently no references for SLC39A13 blocking peptide (GTX31995-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for SLC39A13 blocking peptide (GTX31995-PEP). Be the first to share your experience with this product.
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139